Search Results - "Moshkovich, Olga"

Experiences of children and adolescents living with achondroplasia and their caregivers by Shediac, Renée, Moshkovich, Olga, Gerould, Heather, Ballinger, Rachel, Williams, Agnes, Bellenger, M. Alex, Quinn, Jennifer, Hoover‐Fong, Julie, Mohnike, Klaus, Savarirayan, Ravi, Kelly, Dominique

“…Background Achondroplasia, caused by a pathogenic variant in the fibroblast growth factor receptor 3 gene (FGFR3), leads to significant multisystem…”
Get full text

Challenges and Opportunities to Improve Cervical Cancer Screening Rates in US Health Centers through Patient-Centered Medical Home Transformation by Lin, Sue C., Chung, Michelle, Chidambaran, Preeta, Makaroff, Laura, Lebrun-Harris, Lydie, Moshkovich, Olga, Sripipatana, Alek

“…Over the last 50 years, the incidence of cervical cancer has dramatically decreased. However, health disparities in cervical cancer screening (CCS) persist for…”
Get full text

Content validation of a daily patient-reported outcome measure for assessing symptoms in patients with Small Intestinal Bacterial Overgrowth by Durgam, Neha, Dashputre, Ankur A., Moshkovich, Olga, Rezaie, Ali, Martinez, Nicholas, Enayati, Pedram, Stansbury, James, Joseph, George

“…Purpose The aim of this study was to generate evidence supporting the development and content validity of a new PRO instrument, the Small Intestinal Bacterial…”
Get full text

Patient (pt) Experiences of Receiving Idecabtagene Vicleucel (Ide-Cel, bb2121) Versus Standard (Std) Regimens for the Treatment (Tx) of Relapsed/Refractory Multiple Myeloma (RRMM) in the Randomized, Controlled KarMMa-3 Clinical Trial: Analysis of Longitudinal Qualitative Interviews by Rodríguez Otero, Paula, Patel, Krina K., Raje, Noopur S., Moshkovich, Olga, Gerould, Heather, Devlen, Jennifer, Dhanda, Devender, Eliason, Laurie, Cook, Mark, Popa-McKiver, Mihaela, Manier, Salomon

“…Introduction: Ide-cel is a first-in-class B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell therapy approved by the United States (US)…”
Get full text

Development of a signs and symptoms outcome measure for caregivers of patients with methylmalonic acidemia and propionic acidemia (MMAPAQ) by Sikirica, Vanja, Schwartz, Ethan J., Vockley, Jerry, Stagni, Kathy, Bellenger, M. Alex, Banerjee, Geetanjoli, Durgam, Neha, Moshkovich, Olga

“…Methylmalonic acidemia (MMA) and propionic acidemia (PA) are rare inborn errors of metabolism with shared signs and symptoms that are associated with…”
Get full text

Idecabtagene vicleucel (ide-cel, bb2121), a BCMA-directed CAR T-cell therapy: Qualitative analyses of pretreatment patient interviews in the KarMMa trial by Braverman, Julia, Moshkovich, Olga, Miera, Matthew, Shah, Selam, Brion, Triza, Devlen, Jennifer, Hege, Kristen, Campbell, Timothy Brandon

“…Abstract only 155 Background: Outcomes remain poor in triple-class exposed (to an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody)…”
Get full text

Development of a conceptual model and patient-reported outcome measures for assessing symptoms and functioning in patients with heart failure by Moshkovich, Olga, Benjamin, Katy, Hall, Katie, Murphy, Ryan, von Maltzahn, Robyn, Gorsh, Boris, Sikirica, Vanja, Saini, Rajnish, Sprecher, Dennis

“…Purpose Heart failure (HF) is a common condition that places considerable burden on patients. We aimed to develop a patient-reported outcome (PRO) measure to…”
Get full text

Idecabtagene Vicleucel (ide-cel, bb2121), a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy: Qualitative Analyses of Post-Treatment Interviews (Months 6-24) for Patients with Relapsed and Refractory Multiple Myeloma in the Karmma Clinical Trial by Shah, Nina, Delforge, Michel, Rodríguez-Otero, Paula, Moshkovich, Olga, Braverman, Julia, Dhanda, Devender, Lanar, Sally, Devlen, Jennifer, Miera, Matthew, Gerould, Heather, Campbell, Timothy B., Munshi, Nikhil C.

“…Introduction: Idecabtagene vicleucel (ide-cel), a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell therapy, is approved by the…”
Get full text

Interviews of Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) Enrolled in 2 Lisocabtagene Maraleucel (liso-cel) Trials on Their Treatment Experience for 3 Months after Infusion by Siddiqi, Tanya, Jaeger, Ulrich, Moshkovich, Olga, Braverman, Julia, Liu, Fei Fei, Lanar, Sally, Miera, Matthew, Shah, Selam, Devlen, Jennifer, Salles, Gilles

“…Pts with R/R LBCL had rapid and durable responses with liso-cel, a CD19-directed chimeric antigen receptor (CAR) T cell therapy. Previous qualitative research…”
Get full text

Analysis of patient-reported experiences up to 2 years after receiving idecabtagene vicleucel (ide-cel, bb2121) for relapsed or refractory multiple myeloma: Longitudinal findings from the phase 2 KarMMa trial by Delforge, Michel, Otero, Paula Rodríguez, Shah, Nina, Moshkovich, Olga, Braverman, Julia, Dhanda, Devender S., Lanar, Sally, Devlen, Jennifer, Miera, Matthew, Gerould, Heather, Campbell, Timothy B., Munshi, Nikhil C.

“…To understand the long-term experience of patients receiving ide-cel chimeric antigen receptor T (CAR T) cell therapy for relapsed or refractory multiple…”
Get full text

Patient-Reported Experiences in Voxelotor-Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study by Brown, Clark, Idowu, Modupe, Drachtman, Richard, Beaubrun, Anne, Agodoa, Irene, Nguyen, Andy, Lipman, Kelly, Moshkovich, Olga, Murphy, Ryan, Bellenger, M. Alex, Smith, Wally

“…Objective. Voxelotor is a first-in-class sickle hemoglobin–polymerization inhibitor that was approved in 2019 by the US Food and Drug Administration for…”
Get full text

Development of a metabolic decompensation event severity score for patients with propionic acidemia or methylmalonic acidemia by Schwartz, Ethan J., Longo, Nicola, Perera, Sue, Dionisi-Vici, Carlo, Leuchars, Mary, Burrow, Andrew, Ajayi, Temitayo, de las Heras, Javier, Banerjee, Geetanjoli, Prada, Carlos, Bellenger, M. Alex, Moshkovich, Olga, Sikirica, Vanja

Get full text

Correction to: Development of a conceptual model and patient-reported outcome measures for assessing symptoms and functioning in patients with heart failure by Moshkovich, Olga, Benjamin, Katy, Hall, Katie, Murphy, Ryan, von Maltzahn, Robyn, Gorsh, Boris, Sikirica, Vanja, Saini, Rajnish, Sprecher, Dennis

“…The article Development of a conceptual model and patient-reported outcome measures for assessing symptoms and functioning in patients with heart failure…”
Get full text

Development of a conceptual model for variant late-infantile neuronal ceroid lipofuscinoses type 7 (CLN7) by Cardenas, Jessica A., Romero, Beverly, Moshkovich, Olga, Watts, Ashlee, Visootsak, Jeannie

Get full text

Qualitative Analysis of the Treatment Experience and Well-Being of Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) Enrolled in 2 Trials of Lisocabtagene Maraleucel (liso-cel) during the Initial Stages of Therapy by Siddiqi, Tanya, Jaeger, Ulrich, Moshkovich, Olga, Devlen, Jennifer, Miera, Matthew, Williams, Agnes, Hasskarl, Jens, Liu, Fei Fei, Braverman, Julia, Salles, Gilles

“…Background: Chimeric antigen receptor (CAR) T cell therapy is a novel treatment modality for patients with R/R LBCL. Limited information exists regarding…”
Get full text

Patient experience before and after treatment with idecabtagene vicleucel (ide-cel, bb2121): qualitative analysis of patient interviews in the KarMMa trial by Shah, Nina, Delforge, Michel, San-Miguel, Jesus, Moshkovich, Olga, Braverman, Julia, Dhanda, Devender S., Lanar, Sally, Miera, Matthew, Williams, Agnes, Murphy, Ryan, Devlen, Jennifer, Hege, Kristen, Campbell, Timothy B., Munshi, Nikhil C.

“…To understand the experience of patients with relapsed and refractory multiple myeloma (RRMM) receiving idecabtagene vicleucel (ide-cel), a B-cell maturation…”
Get full text

Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup by Waisbren, Susan E., Christ, Shawn E., Bilder, Deborah A., Bjoraker, Kendra J., Bolton, Scout, Chamberlin, Sarah, Grant, Mitzie L., Janzen, Darren M., Katz, Rachel, Lubliner, Eugene, Martin, Arianna, McQueen, Kelsey, Moshkovich, Olga, Nguyen-Driver, Mina, Shim, Soo, Stefanatos, Arianna K., Wilkening, Greta, Harding, Cary

“…•This White Paper offers a neurocognitive assessment platform for clinical trials in PKU.•It describes 5 neuropsychological domains relevant to outcomes in…”
Get full text

eP140 - Experiences of individuals with achondroplasia and their caregivers: interim results from qualitative studies by Shediac, Renée, Moshkovich, Olga, Lewis, Hannah, Ballinger, Rachel, McGraw, Sarah, Henne, Jeffrey C., Quinn, Jennifer, Chen, Er, Larkin, Adelpha Abrahamson, Kelly, Dominique

Get full text

Experiences of individuals with achondroplasia and their caregivers: interim results from qualitative studies by Shediac, Renée, Moshkovich, Olga, Lewis, Hannah, Ballinger, Rachel, McGraw, Sarah, Henne, Jeffrey C., Quinn, Jennifer, Chen, Er, Larkin, Adelpha Abrahamson, Kelly, Dominique

Get full text

A New Measure Assessing Recovery from a Sickle Cell Crisis by Vendetti, Nicholas J., Benjamin, Katy, Moshkovich, Olga, Lipman, Kelly, Sivamurthy, Krupa M., Pleil, Andreas M.

“…Rationale: Vaso-occlusive crisis (VOC) is a recurring complication of sickle cell disease (SCD) and a common reason for emergency department visits and…”
Get full text